ID23861A - Turunan-turunan aminopirimidina - Google Patents

Turunan-turunan aminopirimidina

Info

Publication number
ID23861A
ID23861A IDW991160A ID991160A ID23861A ID 23861 A ID23861 A ID 23861A ID W991160 A IDW991160 A ID W991160A ID 991160 A ID991160 A ID 991160A ID 23861 A ID23861 A ID 23861A
Authority
ID
Indonesia
Prior art keywords
aminopirimidine
demons
Prior art date
Application number
IDW991160A
Other languages
English (en)
Indonesian (id)
Inventor
Thomas Mcinally
Alan Tinker
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of ID23861A publication Critical patent/ID23861A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IDW991160A 1997-04-09 1998-04-07 Turunan-turunan aminopirimidina ID23861A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9701304A SE9701304D0 (sv) 1997-04-09 1997-04-09 Compounds

Publications (1)

Publication Number Publication Date
ID23861A true ID23861A (id) 2000-05-25

Family

ID=20406499

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991160A ID23861A (id) 1997-04-09 1998-04-07 Turunan-turunan aminopirimidina

Country Status (21)

Country Link
US (1) US6303613B1 (xx)
EP (1) EP0973772A1 (xx)
JP (1) JP2001519805A (xx)
KR (1) KR20010006143A (xx)
CN (1) CN1259131A (xx)
AU (1) AU7091098A (xx)
BR (1) BR9807950A (xx)
CA (1) CA2285388A1 (xx)
CZ (1) CZ355199A3 (xx)
EE (1) EE9900448A (xx)
HU (1) HUP0001865A2 (xx)
ID (1) ID23861A (xx)
IL (1) IL132085A0 (xx)
IS (1) IS5208A (xx)
NO (1) NO994900L (xx)
NZ (1) NZ338006A (xx)
PL (1) PL336141A1 (xx)
SE (1) SE9701304D0 (xx)
SK (1) SK128999A3 (xx)
TR (1) TR199902495T2 (xx)
WO (1) WO1998045294A1 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
SE9901530D0 (sv) * 1999-04-28 1999-04-28 Astra Pharma Prod Novel compounds
WO2002005799A2 (en) * 2000-07-13 2002-01-24 Pharmacia Corporation Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain
AU7090201A (en) 2000-07-20 2002-02-05 Lauras As Method
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US20040034083A1 (en) * 2002-04-18 2004-02-19 Stephenson Diane T. Combination therapy for the treatment of Parkinson's disease with cyclooxygenase-2 (COX2) inhibitor(s)
CA2482510A1 (en) * 2002-04-18 2003-10-30 Pharmacia Corporation Monotherapy for the treatment of parkinson`s disease with cyclooxygenase-2 (cox 2) inhibitor(s)
AU2003260033A1 (en) * 2002-08-29 2004-03-19 Schering Aktiengesellschaft Methods of treating acute respiratory distress syndrome
AU2004204825B2 (en) * 2003-01-13 2007-07-19 Dynogen Pharmaceuticals, Inc. Method of treating functional bowel disorders
EP1626961B1 (en) * 2003-05-17 2011-11-02 Korea Research Institute of Bioscience and Biotechnology Novel 2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same
DE102005024012A1 (de) * 2005-05-20 2006-11-23 Grünenthal GmbH Verwendung von 2,5-disubstituierten Thiazol-4-on-Derivaten in Arzneimitteln
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
MX2008002733A (es) * 2005-09-01 2008-03-26 Hoffmann La Roche Diaminopirimidinas como moduladores p2x3 y p2x2/3.
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
JP2011524896A (ja) 2008-06-18 2011-09-08 アストラゼネカ・アクチエボラーグ 呼吸器障害の処置用のベータ２−アドレナリン受容体アゴニストとして作用するベンズオキサジノン誘導体
US20240165148A1 (en) 2021-03-15 2024-05-23 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3403152A (en) 1967-03-20 1968-09-24 Ciba Geigy Corp 1-aryl-4-imino-1, 2, 3, 4-tetrahydroquinazolines
US3483205A (en) 1967-12-22 1969-12-09 Ciba Geigy Corp Bicyclic tetrahydropyrimidines
SE9703693D0 (sv) * 1997-10-10 1997-10-10 Astra Pharma Prod Novel combination

Also Published As

Publication number Publication date
CZ355199A3 (cs) 2000-03-15
CN1259131A (zh) 2000-07-05
SE9701304D0 (sv) 1997-04-09
HUP0001865A2 (hu) 2001-01-29
NO994900L (no) 1999-11-19
JP2001519805A (ja) 2001-10-23
SK128999A3 (en) 2000-05-16
MX9909188A (en) 2001-07-01
TR199902495T2 (xx) 2000-07-21
CA2285388A1 (en) 1998-10-15
NO994900D0 (no) 1999-10-08
PL336141A1 (en) 2000-06-05
EP0973772A1 (en) 2000-01-26
IS5208A (is) 1999-10-05
US6303613B1 (en) 2001-10-16
BR9807950A (pt) 2000-03-08
KR20010006143A (ko) 2001-01-26
WO1998045294A1 (en) 1998-10-15
AU7091098A (en) 1998-10-30
EE9900448A (et) 2000-04-17
IL132085A0 (en) 2001-03-19
NZ338006A (en) 2001-04-27

Similar Documents

Publication Publication Date Title
ID21194A (id) Turunan-turunan d-prolina
ID18623A (id) Turunan-turunan naftiridin
ID26277A (id) Turunan-turunan kuinolina
ID16969A (id) Turunan-turunan aril pirimidin
NO996108D0 (no) 9-oksinerytromycinderivater
ID24669A (id) Turunan-turunan dolastatin 15
ID23861A (id) Turunan-turunan aminopirimidina
ID17440A (id) Turunan-turunan peptida
ID19801A (id) Turunan-turunan 5'-deoksi-sitidina
ID16037A (id) Turunan-turunan peptida
ID29173A (id) Turunan-turunan karbapenem
ID27030A (id) Turunan-turunan higromisin a
NO960353D0 (no) 4-aminobenzoylguanidinderivater
BR9709521A (pt) "3-Cianoaril-pirazóis"
NO960392L (no) 4-merkaptobenzoylguanidinderivater
ID28848A (id) Turunan-turunan higromisin a
FR2758444B1 (fr) Boucles d'oreille
FR2735986B3 (fr) Prolongateur d'haltere
ID21890A (id) Turunan-turunan piperidina
ID16747A (id) Turunan-turunan kuinolina
FR2724251B3 (fr) Structure d'etiquetage
KR960001317U (ko) 카스테레오의 고정구조
ITCS970006V0 (it) "1 m"
KR970019493U (ko) 브이씨알의 케이스
UA1645S (uk) Шрифт "брунька"